Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration
Michael F. Kanan, Patrick W. Sheehan, Jessica N. Haines, Pedro G. Gomez, Adya Dhuler, Collin J. Nadarajah, Zachary M. Wargel, Brittany M. Freeberg, Hemanth R. Nelvagal, Mariko Izumo, Joseph S. Takahashi, Jonathan D. Cooper, Albert A. Davis, Erik S. Musiek
Michael F. Kanan, Patrick W. Sheehan, Jessica N. Haines, Pedro G. Gomez, Adya Dhuler, Collin J. Nadarajah, Zachary M. Wargel, Brittany M. Freeberg, Hemanth R. Nelvagal, Mariko Izumo, Joseph S. Takahashi, Jonathan D. Cooper, Albert A. Davis, Erik S. Musiek
View: Text | PDF | Corrigendum
Research Article Aging Neuroscience

Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration

  • Text
  • PDF
Abstract

Circadian rhythm dysfunction is a hallmark of Parkinson disease (PD), and diminished expression of the core clock gene Bmal1 has been described in patients with PD. BMAL1 is required for core circadian clock function but also serves nonrhythmic functions. Germline Bmal1 deletion can cause brain oxidative stress and synapse loss in mice, and it can exacerbate dopaminergic neurodegeneration in response to the toxin MPTP. Here we examined the effect of cell type–specific Bmal1 deletion on dopaminergic neuron viability in vivo. We observed that global, postnatal deletion of Bmal1 caused spontaneous loss of tyrosine hydroxylase+ (TH+) dopaminergic neurons in the substantia nigra pars compacta (SNpc). This was not replicated by light-induced disruption of behavioral circadian rhythms and was not induced by astrocyte- or microglia-specific Bmal1 deletion. However, either pan-neuronal or TH neuron–specific Bmal1 deletion caused cell-autonomous loss of TH+ neurons in the SNpc. Bmal1 deletion did not change the percentage of TH neuron loss after α-synuclein fibril injection, though Bmal1-KO mice had fewer TH neurons at baseline. Transcriptomics analysis revealed dysregulation of pathways involved in oxidative phosphorylation and Parkinson disease. These findings demonstrate a cell-autonomous role for BMAL1 in regulating dopaminergic neuronal survival and may have important implications for neuroprotection in PD.

Authors

Michael F. Kanan, Patrick W. Sheehan, Jessica N. Haines, Pedro G. Gomez, Adya Dhuler, Collin J. Nadarajah, Zachary M. Wargel, Brittany M. Freeberg, Hemanth R. Nelvagal, Mariko Izumo, Joseph S. Takahashi, Jonathan D. Cooper, Albert A. Davis, Erik S. Musiek

×

Figure 4

Transcriptomics analysis of midbrain tissue from Bmal1-KO mice reveals dysregulation of pathways related to Parkinson disease and oxidative phosphorylation.

Options: View larger image (or click on image) Download as PowerPoint
Transcriptomics analysis of midbrain tissue from Bmal1-KO mice reveals d...
(A) Expression of known BMAL1 transcriptional targets in cortex from Cre–;Bmalfl/fl control and Camk2a-iCre;Bmalfl/fl neuron-specific Bmal1-KO mice at 4 months old. n = 3 mice/genotype. (B) Volcano plot showing differentially expressed genes (DEGs) in cortex tissue from Camk2a-iCre;Bmalfl/fl neuron-specific Bmal1-KO mice, as compared with Cre– controls. DEGs with fold change > 2 and uncorrected P < 0.05 are shown in red. Data are derived from n = 3 mice/genotype. (C) KEGG pathway analysis of all DEGs which were up- or downregulation in Camk2a-iCre;Bmalfl/fl cortex with multiple-comparison adjusted P < 0.05. (D) Exploratory volcano plot showing DEGs (DEGs) in midbrain tissue from CAG-CreERt2+;Bmal1fl/fl mice, as compared with Cre– controls. DEGs with fold change > 2 and uncorrected P < 0.05 are shown in red. Fabp7 is not shown but is highly significant and upregulated off scale. Data are derived from n = 3 Cre– and n = 2 Cre+ mice. (E) Exploratory KEGG pathway analysis of all DEGs that were up- or downregulation in Cre+ midbrain samples with multiple-comparison adjusted P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts